Private equity firm Advent International said on Tuesday that in its all-cash public offer for Mediq N.V shares
Healthcare Health/Fitness
Cangene Corp Terminates Acquisition of Hemophilia Compound IB1001 Amidst Inspiration's Bankruptcy Proceedings
Cangene has decided to close its acquisition of the hemophilia compound as Inspiration Biopharmaceuticals faces bankruptcy proceedings.
Aeolus Pharmaceuticals Reaches Purchase Agreement for $3.2 Million Private Placement Financing
Aeolus enters agreement with accredited investors on private placement financing worth of 3.2 million dollars
OPKO Health Completes Acquisition of Brazilian Pharmaceutical Company
OPKO Health announced that is has completed the acquisition of Silcon Comércio OPKO Health, Inc. (NYSE: OPK) announced that is has completed the acquisition of Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos Ltda.
Biogen's Purchase of Multiple Sclerosis Drug Ends Rocky Partnership with Elan
Biogen Idec agreement to buy Elan Corp's interest in the multiple sclerosis drug Tysabri gives Biogen full control of a product that is poised for further growth and ends a long partnership that has often been contentious.
Latest News
Bids, mergers, acquisitions and disposals on Thursday The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Thursday:- Amazon.
Venture capital funding to focus on enhanced drug delivery and product life cycle management technologies
Bids, mergers, acquisitions and disposals reported on Wednesday The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Wednesday:- Private equity firm Electra has hired Rothschild to explore a sale or a refinancing of electronic animal identification company Allflex, which is worth about $1 billion, four industry sources with knowledge of the plan said.
Partnership combines HealthCanal's news headlines with the leading industry reach and resources of UBM Medica US
Watson Pharmaceuticals today announced that it has completed the acquisition of Belgium-based Uteron Pharma SA for $150 million in cash up front
Progenics Pharmaceuticals today announced that it has acquired Molecular Insight Pharmaceuticals Acquires Molecular Insight Pharmaceuticals to expand oncology-focused pipeline Exchanged about 4.
The possible takeover news has resulted in the shares in Life Technology gaining more than 10 percent to $60.79.
Even as consumer companies and prescription drug-makers zero in on emerging opportunities in the OTC healthcare market, global consumer goods major Reckitt Benckiser has inked a deal to acquire US group Schiff Nutrition for $1.4 billion.
Wall Street's post-election sell-off may gather steam in the coming weeks as worries mount about the looming "fiscal cliff" and technical weakness suggests a possible correction ahead.
